1. Home
  2. BFC vs NNNN Comparison

BFC vs NNNN Comparison

Compare BFC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$128.24

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$34.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
NNNN
Founded
1894
2021
Country
United States
Germany
Employees
N/A
27
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BFC
NNNN
Price
$128.24
$34.00
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$142.00
N/A
AVG Volume (30 Days)
62.3K
37.8K
Earning Date
01-20-2026
04-28-2026
Dividend Yield
1.42%
N/A
EPS Growth
N/A
N/A
EPS
7.11
0.06
Revenue
$168,778,000.00
$8,185,146.00
Revenue This Year
$11.79
N/A
Revenue Next Year
$32.03
N/A
P/E Ratio
$17.85
$619.66
Revenue Growth
N/A
21.95
52 Week Low
$92.49
$5.18
52 Week High
$139.71
$55.65

Technical Indicators

Market Signals
Indicator
BFC
NNNN
Relative Strength Index (RSI) 42.78 54.45
Support Level $132.74 $31.18
Resistance Level $137.56 $35.55
Average True Range (ATR) 3.18 5.14
MACD -0.88 0.14
Stochastic Oscillator 1.53 37.79

Price Performance

Historical Comparison
BFC
NNNN

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: